These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 6251492

  • 1. The influence of epinephrine on prostacyclin (PGI2) induced dissociation of ADP aggregated plateletes.
    Rao GH, Reddy KR, White JG.
    Prostaglandins Med; 1980 Jun; 4(6):385-97. PubMed ID: 6251492
    [Abstract] [Full Text] [Related]

  • 2. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S, Westwick J, Kakkar VV.
    Biochem Pharmacol; 1984 Oct 01; 33(19):3025-35. PubMed ID: 6091666
    [Abstract] [Full Text] [Related]

  • 3. Intracellular levels of cyclic AMP and cyclic GMP differentially modify platelet aggregate size in human platelets activated with epinephrine or ADP.
    Qi R, Ozaki Y, Satoh K, Yang LB, Asazuma N, Yatomi Y, Kume S.
    J Cardiovasc Pharmacol; 1996 Aug 01; 28(2):215-22. PubMed ID: 8856476
    [Abstract] [Full Text] [Related]

  • 4. Sub-aggregatory doses of catecholamines prevent prostacyclin-induced inhibition of platelet aggregation.
    Buttrick PM, Forscher CA, Sussman II, Mueller HS.
    Am Heart J; 1985 Jun 01; 109(6):1258-63. PubMed ID: 2988323
    [Abstract] [Full Text] [Related]

  • 5. Influence of trifluoperazine on platelet aggregation and disaggregation.
    Rao GH, Reddy KR, White JG.
    Prostaglandins Med; 1980 Sep 01; 5(3):221-34. PubMed ID: 6251499
    [Abstract] [Full Text] [Related]

  • 6. The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers.
    Reele SB, Miller OV, Spillers C, Gorman RR.
    Prostaglandins; 1983 Aug 01; 26(2):287-302. PubMed ID: 6316420
    [Abstract] [Full Text] [Related]

  • 7. 6-Keto-prostaglandin E1 inhibits the aggregation of human platelets.
    Wong PY, McGiff JC, Sun FF, Lee WH.
    Eur J Pharmacol; 1979 Dec 07; 60(2-3):245-8. PubMed ID: 393526
    [Abstract] [Full Text] [Related]

  • 8. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.
    Fisher CA, Kappa JR, Sinha AK, Cottrell ED, Reiser HJ, Addonizio VP.
    J Lab Clin Med; 1987 Feb 07; 109(2):184-90. PubMed ID: 2433373
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin.
    Beretz A, Stierle A, Anton R, Cazenave JP.
    Biochem Pharmacol; 1982 Nov 15; 31(22):3597-600. PubMed ID: 6295405
    [Abstract] [Full Text] [Related]

  • 12. Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood.
    Saniabadi AR, Belch JJ, Lowe GD, Barbenel JC, Forbes CD.
    Haemostasis; 1987 Nov 15; 17(3):147-53. PubMed ID: 2440771
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of platelet aggregation and elevation of cyclic-AMP levels in platelets by 13,14-dehydro PGI2 methyl ester.
    Malmsten C, Claesson HE, Fried J.
    Prostaglandins Med; 1980 Jun 15; 4(6):453-63. PubMed ID: 6251494
    [Abstract] [Full Text] [Related]

  • 14. Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic patients.
    Onodera H, Hirata T, Sugawara H, Sugai K, Yoda B, Toyota T, Goto Y.
    Tohoku J Exp Med; 1982 Aug 15; 137(4):423-8. PubMed ID: 6750843
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory effects of diltiazem on platelet activation caused by ionophore A23187 plus ADP or epinephrine in subthreshold concentrations.
    Mehta P, Mehta J, Ostrowski N, Brigmon L.
    J Lab Clin Med; 1983 Sep 15; 102(3):332-9. PubMed ID: 6411841
    [Abstract] [Full Text] [Related]

  • 16. Synergistic inhibition of platelet activation by plasmin and prostaglandin I2.
    Schafer AI, Zavoico GB, Loscalzo J, Maas AK.
    Blood; 1987 May 15; 69(5):1504-7. PubMed ID: 3032310
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.